Article No
246-K67s
Rabbit anti Bisphenol A
Rabbit anti Bisphenol A
Antibodies Primary
Specifications
| Application | ELISA, Chromatography |
| Article No | 246-K67s |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
| Clone | Polyclonal |
| Clone Type | polyclonal |
| Cross Reactivity | Cross Reactivity in a direct assay Molecules containing a phenolic group % Cross Reactivity Bisphenol A 100% 4,4'-(ethylidene) bisphenol 10% Bis-(4-hydroxy phenyl)-methane 1% Nonylphenol 0.1% 4-cumylphenol 1% Molecules lacking a phenolic group % Cross Reactivity Vinclozolin 0.1% Pirimifos-ethyl < 0.1% 17ß-Estradiol < 0.1% Sulfadimidine < 0.1% Cross Reactivity in an indirect assay Molecules containing a phenolic group % Cross Reactivity Bisphenol A 100% 4,4'-(ethylidene) bisphenol 10% 4-cumylphenol 10% Molecules lacking a phenolic group % Cross Reactivity Vinclozolin <0.1% Pirimifos-ethyl < 0.1% 2,4 D < 0.1% Fenitrothion < 0.1% Chlorpyrifos-methyl < 0.1% Erythromycine < 0.1% |
| Description | Rabbit anti Bisphenol A |
| Supplier | Nordic - MUbio |
| Immunogen | BSA-Bisphenol Valeric Acid (BVA) |
| Isotype | Ig |
| Notes | Bisphenol A (BPA) is predominantly used in the production of polycarbonate plastics and epoxy resins that are used in many products. It is released into the environment and food. BPA is an endocrine disruptor with estrogenic and obesogenic properties. It influences reproduction and has an epigenetic effect already in the foetus. |
| Previous Article No | 246-K67s |
| Product Type | Antibodies Primary |
| Protocol | Dilution of 1/50,000 from the delivered solution. (The titer is defined as the dilution that gives 50 % of the absorbance from the maximum absorbance when tested with ELISA). Suggested concentration to use in ELISA: 1/50,000 from the delivered solution. Plates are coated with 400 ng/ml OVA-Bisphenol Valeric Acid (BVA). HRP-conjugated anti-rabbit IgG as a tracer 1/8,000 |
| Size | 0.1 ml |
| Source / Host | rabbit |
| Storage | Store at 4 °C or aliquot and store at -20 °C for longer periods. Precautions should be taken upon storage for longer periods. Problems of long term stability may occur with highly diluted solutions. For long storage purposes in solution the addition of sodium azide at 0.02 % is advised with the appropriate precautions of use. |
| Substrate / Buffer | Each vial contains 0.1 ml of serum |
| Technical Specifications | Each vial contains 0.1 ml of serum |
| Product Page Updated | 2024-01-31T10:35:40.347Z |
